<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN"
 "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <meta name="copyright" content="metrumrg &copy 2021"/>
  <meta name="font-size-adjustment" content="3"/>
  <title>Confounded Exposure Response</title>
  <style type="text/css">
    code{white-space: pre-wrap;}
    span.smallcaps{font-variant: small-caps;}
    span.underline{text-decoration: underline;}
    div.column{display: inline-block; vertical-align: top; width: 50%;}
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
    ul.task-list{list-style: none;}
            a.sourceLine { display: inline-block; line-height: 1.25; }
    a.sourceLine { pointer-events: none; color: inherit; text-decoration: inherit; }
    a.sourceLine:empty { height: 1.2em; }
    .sourceCode { overflow: visible; }
    code.sourceCode { white-space: pre; position: relative; }
    div.sourceCode { margin: 1em 0; }
    pre.sourceCode { margin: 0; }
    @media screen {
    div.sourceCode { overflow: auto; }
    }
    @media print {
    code.sourceCode { white-space: pre-wrap; }
    a.sourceLine { text-indent: -1em; padding-left: 1em; }
    }
    pre.numberSource a.sourceLine
      { position: relative; left: -4em; }
    pre.numberSource a.sourceLine::before
      { content: attr(data-line-number);
        position: relative; left: -1em; text-align: right; vertical-align: baseline;
        border: none; pointer-events: all; display: inline-block;
        -webkit-touch-callout: none; -webkit-user-select: none;
        -khtml-user-select: none; -moz-user-select: none;
        -ms-user-select: none; user-select: none;
        padding: 0 4px; width: 4em;
        color: #aaaaaa;
      }
    pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa;  padding-left: 4px; }
    div.sourceCode
      {  }
    @media screen {
    a.sourceLine::before { text-decoration: underline; }
    }
    code span.al { color: #ff0000; font-weight: bold; } /* Alert */
    code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } /* Annotation */
    code span.at { color: #7d9029; } /* Attribute */
    code span.bn { color: #40a070; } /* BaseN */
    code span.bu { } /* BuiltIn */
    code span.cf { color: #007020; font-weight: bold; } /* ControlFlow */
    code span.ch { color: #4070a0; } /* Char */
    code span.cn { color: #880000; } /* Constant */
    code span.co { color: #60a0b0; font-style: italic; } /* Comment */
    code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } /* CommentVar */
    code span.do { color: #ba2121; font-style: italic; } /* Documentation */
    code span.dt { color: #902000; } /* DataType */
    code span.dv { color: #40a070; } /* DecVal */
    code span.er { color: #ff0000; font-weight: bold; } /* Error */
    code span.ex { } /* Extension */
    code span.fl { color: #40a070; } /* Float */
    code span.fu { color: #06287e; } /* Function */
    code span.im { } /* Import */
    code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } /* Information */
    code span.kw { color: #007020; font-weight: bold; } /* Keyword */
    code span.op { color: #666666; } /* Operator */
    code span.ot { color: #007020; } /* Other */
    code span.pp { color: #bc7a00; } /* Preprocessor */
    code span.sc { color: #4070a0; } /* SpecialChar */
    code span.ss { color: #bb6688; } /* SpecialString */
    code span.st { color: #4070a0; } /* String */
    code span.va { color: #19177c; } /* Variable */
    code span.vs { color: #4070a0; } /* VerbatimString */
    code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } /* Warning */
          </style>
  <style type="text/css">
a.sourceLine { display: inline-block; line-height: 1.25; }
a.sourceLine { pointer-events: none; color: inherit; text-decoration: inherit; }
a.sourceLine:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode { white-space: pre; position: relative; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
code.sourceCode { white-space: pre-wrap; }
a.sourceLine { text-indent: -1em; padding-left: 1em; }
}
pre.numberSource a.sourceLine
  { position: relative; left: -4em; }
pre.numberSource a.sourceLine::before
  { content: attr(data-line-number);
    position: relative; left: -1em; text-align: right; vertical-align: baseline;
    border: none; pointer-events: all; display: inline-block;
    -webkit-touch-callout: none; -webkit-user-select: none;
    -khtml-user-select: none; -moz-user-select: none;
    -ms-user-select: none; user-select: none;
    padding: 0 4px; width: 4em;
    color: #aaaaaa;
  }
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa;  padding-left: 4px; }
div.sourceCode
  {  }
@media screen {
a.sourceLine::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } /* Alert */
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } /* Annotation */
code span.at { color: #7d9029; } /* Attribute */
code span.bn { color: #40a070; } /* BaseN */
code span.bu { } /* BuiltIn */
code span.cf { color: #007020; font-weight: bold; } /* ControlFlow */
code span.ch { color: #4070a0; } /* Char */
code span.cn { color: #880000; } /* Constant */
code span.co { color: #60a0b0; font-style: italic; } /* Comment */
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } /* CommentVar */
code span.do { color: #ba2121; font-style: italic; } /* Documentation */
code span.dt { color: #902000; } /* DataType */
code span.dv { color: #40a070; } /* DecVal */
code span.er { color: #ff0000; font-weight: bold; } /* Error */
code span.ex { } /* Extension */
code span.fl { color: #40a070; } /* Float */
code span.fu { color: #06287e; } /* Function */
code span.im { } /* Import */
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } /* Information */
code span.kw { color: #007020; font-weight: bold; } /* Keyword */
code span.op { color: #666666; } /* Operator */
code span.ot { color: #007020; } /* Other */
code span.pp { color: #bc7a00; } /* Preprocessor */
code span.sc { color: #4070a0; } /* SpecialChar */
code span.ss { color: #bb6688; } /* SpecialString */
code span.st { color: #4070a0; } /* String */
code span.va { color: #19177c; } /* Variable */
code span.vs { color: #4070a0; } /* VerbatimString */
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } /* Warning */
  </style>
  <link href="Confounded-Exposure-Respose_files/slidy-2/styles/slidy.css" rel="stylesheet" />
  <script src="Confounded-Exposure-Respose_files/slidy-2/scripts/slidy.js"></script>
  <script src="Confounded-Exposure-Respose_files/slidy_shiny-1/slidy_shiny.js"></script>
  <link rel="stylesheet" type="text/css" media="screen, projection, print"
   href="slidystyles.css" />
</head>
<body>
<div class="slide titlepage">
  <h1 class="title">Confounded Exposure Response</h1>
  <p class="author">

  </p>
</div>
<div id="outline" class="slide section level1">
<h1>Outline</h1>
<ul>
<li>Introduction and example: Trastuzumab in mGC</li>
<li>What is confounding?</li>
<li>Why is it a problem?</li>
<li>Thinking causally</li>
<li>What are some solutions?</li>
</ul>
</div>
<div id="understanding-exposure-response-relationships-is-a-key-component-of-decision-making" class="slide section level1">
<h1>Understanding exposure-response relationships is a key component of decision-making</h1>
<p>For example,</p>
<ul>
<li>Sponsors: Dose-selection for future trials or registration</li>
<li>Regulators: “Optimizing” benefit-risk in a population</li>
<li>Physicians: “Optimizing” benefit-risk for a patient</li>
</ul>
</div>
<div id="in-some-development-programs-only-one-dose-is-studied-extensively" class="slide section level1">
<h1>In some development programs, only one dose is studied extensively</h1>
<ul>
<li>Common practice in oncology
<ul>
<li>Find MTD -&gt; run expansion cohort (Phase 1b/2) -&gt; Phase 3</li>
</ul></li>
<li>Not uncommon in other disease areas
<ul>
<li>Expense of producing dosage forms or amounts</li>
<li>Success at MTD</li>
<li>“Fast to market” strategies</li>
</ul></li>
</ul>
</div>
<div id="with-biologics-this-can-cause-a-problem" class="slide section level1">
<h1>With biologics this can cause a problem</h1>
<ul>
<li>Observe an apparent exposure-response
<ul>
<li>This may be real</li>
<li>May be due to other factors</li>
</ul></li>
</ul>
<div class="columns">
<div class="column">
<ul>
<li>Oncology
<ul>
<li>Trastuzumab</li>
<li>Trastuzumab emtansine (T-DM1)</li>
<li>Nivolumab</li>
<li>Pembrolizumab</li>
<li>Avelumab</li>
<li>Ipilimumab</li>
</ul></li>
</ul>
</div><div class="column">
<ul>
<li>Ulcerative colitis
<ul>
<li>Infliximab</li>
<li>Vedolizumab</li>
</ul></li>
</ul>
</div>
</div>
</div>
<div id="toga-trastuzumab-in-metastatic-gastric-cancer" class="slide section level1">
<h1>ToGA: Trastuzumab in metastatic gastric cancer</h1>
<div style="display: grid; grid-template-columns: 50% 50%; grid-column-gap: 10px;">
<div>
<p>ToGA trial demonstrated benefit of trastuzumab in mGC, but possibly less effective in patients with low exposure</p>
<ul>
<li>Phase 3, randomized, OL study
<ul>
<li>Fluoropyrimidine and cisplatin (FC) vs. trastuzumab + FC (T+FC)</li>
<li>Trastuzumab dosed with ‘standard’ regimen</li>
<li>Overall effect (top panel <span class="citation">@Bang2010-lp</span>)</li>
<li>By <span class="math inline">\(C_{\text{min},1}\)</span> quartile (bottom panel <span class="citation">@Yang2013-tr</span>)</li>
</ul></li>
</ul>
<p>Led to a trial designed to compare a standard and high-dose trastuzumab regimens.</p>
</div>
<div>
<p><img src="graphics/ToGA-overall.png" width="60%" style="display: block; margin: auto auto auto 0;" /></p>
<p><img src="graphics/Yang-Figure1A.png" width="60%" style="display: block; margin: auto auto auto 0;" /></p>
</div>
</div>
</div>
<div id="the-analysis-of-toga-led-to-the-heloise-trial" class="slide section level1">
<h1>The analysis of ToGA led to the HELOISE trial</h1>
<div style="display: grid; grid-template-columns: 50% 50%; grid-column-gap: 10px;">
<div>
<p>HELOISE trial demonstrated no additional benefit of high dose trastuzumab in mGC</p>
<ul>
<li>Phase 3b, randomized, OL study in 1L mGC
<ul>
<li>Trastuzumab standard regimen vs high-dose regimen</li>
<li>Both regimens included cisplatin + capecitabine</li>
</ul></li>
<li>Top panel: overall effect (<span class="citation">@Shah2017-yo</span>)</li>
<li>Bottom panel: Effect in low <span class="math inline">\(C_{\text{min},1}\)</span> group (<span class="citation">@Shah2017-yo</span>)</li>
</ul>
</div>
<div>
<p><img src="graphics/HELOISE-overall.png" width="60%" style="display: block; margin: auto auto auto 0;" /></p>
<p><img src="graphics/HELOISE-subset.png" width="60%" style="display: block; margin: auto auto auto 0;" /></p>
</div>
</div>
</div>
<div id="what-happened" class="slide section level1">
<h1>What happened?</h1>
<ul>
<li><p>The apparent exposure-response in the ToGA trial was an artifact of <red>confounding</red></p></li>
<li><p>Subsequent analyses (<span class="citation">@Yang2013-tr</span>) confirmed the lack of an exposure-response relationship in the ToGA study.</p></li>
</ul>
<!-- # This observation is common with large molecules which are studied at one dose -->
<!-- << give other examples: T-DM1, tremi, vedo >> -->
<!-- * Why is this a particular problem for large molecules? -->
<!-- * Why is that compounded when studying a single dose regimen? -->
</div>
<div id="what-is-confounding" class="slide section level1">
<h1>What is confounding?</h1>
<ul>
<li>Our primary interest is in the <red>causal</red> effect of exposure on an outcome.
<ul>
<li><em>If we change exposure, how does the response change?</em></li>
</ul></li>
<li><red>Confounding</red> is a bias in the estimate of the causal effect.</li>
<li>Occurs when there is a <red>common cause</red> of exposure and the outcome.</li>
</ul>
<div class="notebox">
<p>Exposure-response confounding occurs when there is a common cause of exposure and the outcome of interest.</p>
</div>
</div>
<div id="how-does-a-common-cause-introduce-bias" class="slide section level1">
<h1>How does a common cause introduce bias?</h1>
<ul>
<li>Suppose there is no relationship between exposure (E) and the outcome (O)</li>
<li>There is one common cause (A) of both</li>
<li>We can represent this in a <em>directed acyclic graph</em> (DAG)</li>
</ul>
<p><img src="Confounded-Exposure-Respose_files/figure-slidy/unnamed-chunk-6-1.png" width="864" style="display: block; margin: auto auto auto 0;" /></p>
<ul>
<li>This induces a relationship between exposure and outcome
<ul>
<li>Even though there is no causal effect of exposure on the outcome</li>
<li><em>Association is not causation</em></li>
</ul></li>
</ul>
</div>
<div id="simulated-data" class="slide section level1">
<h1>Simulated data</h1>
<div class="sourceCode" id="cb1"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb1-1" data-line-number="1">simulated_data &lt;-<span class="st"> </span><span class="kw">tibble</span>(</a>
<a class="sourceLine" id="cb1-2" data-line-number="2">  <span class="dt">A =</span> <span class="kw">rnorm</span>(<span class="dv">100</span>),</a>
<a class="sourceLine" id="cb1-3" data-line-number="3">  <span class="dt">E =</span> <span class="kw">exp</span>(<span class="op">-</span><span class="dv">2</span> <span class="op">+</span><span class="st"> </span>A <span class="op">+</span><span class="st"> </span><span class="kw">rnorm</span>(<span class="dv">100</span>,<span class="dt">sd=</span><span class="fl">0.2</span>)),</a>
<a class="sourceLine" id="cb1-4" data-line-number="4">  <span class="dt">O =</span> <span class="dv">10</span> <span class="op">+</span><span class="st"> </span>A <span class="op">+</span><span class="st"> </span><span class="kw">rnorm</span>(<span class="dv">100</span>)  <span class="co"># No direct link between E and O</span></a>
<a class="sourceLine" id="cb1-5" data-line-number="5">)</a></code></pre></div>
<p><img src="Confounded-Exposure-Respose_files/figure-slidy/unnamed-chunk-8-1.png" width="864" style="display: block; margin: auto auto auto 0;" /></p>
</div>
<div id="the-same-type-of-problem-can-occur-when-there-is-an-e-r-relationship" class="slide section level1">
<h1>The same type of problem can occur when there is an E-R relationship</h1>
<div class="columns">
<div class="column">
<p><img src="Confounded-Exposure-Respose_files/figure-slidy/unnamed-chunk-9-1.png" width="864" style="display: block; margin: auto auto auto 0;" /></p>
<ul>
<li>The apparent relationship will differ from the causal one</li>
</ul>
</div><div class="column">
<div class="sourceCode" id="cb2"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb2-1" data-line-number="1">simulated_data &lt;-<span class="st"> </span><span class="kw">tibble</span>(</a>
<a class="sourceLine" id="cb2-2" data-line-number="2">  <span class="dt">A =</span> <span class="kw">rnorm</span>(<span class="dv">100</span>),</a>
<a class="sourceLine" id="cb2-3" data-line-number="3">  <span class="dt">E =</span> <span class="kw">exp</span>(<span class="op">-</span><span class="dv">2</span> <span class="op">+</span><span class="st"> </span>A <span class="op">+</span><span class="st"> </span><span class="kw">rnorm</span>(<span class="dv">100</span>,<span class="dt">sd=</span><span class="fl">0.2</span>)),</a>
<a class="sourceLine" id="cb2-4" data-line-number="4">  <span class="dt">O =</span> <span class="dv">10</span> <span class="op">+</span><span class="st"> </span>A <span class="op">+</span><span class="st"> </span><span class="dv">-4</span><span class="op">*</span>E <span class="op">+</span><span class="st"> </span><span class="kw">rnorm</span>(<span class="dv">100</span>)  <span class="co"># E reduces O</span></a>
<a class="sourceLine" id="cb2-5" data-line-number="5">)</a></code></pre></div>
<p><img src="Confounded-Exposure-Respose_files/figure-slidy/unnamed-chunk-11-1.png" width="864" style="display: block; margin: auto auto auto 0;" /></p>
</div>
</div>
</div>
<div id="simple-dag-for-the-trastuzumab-example" class="slide section level1">
<h1>Simple DAG for the trastuzumab example</h1>
<p><img src="Confounded-Exposure-Respose_files/figure-slidy/unnamed-chunk-12-1.png" width="864" style="display: block; margin: auto auto auto 0;" /></p>
<p><strong>Weight:</strong> <em>baseline</em> factor indirectly affecting exposure (through CL)</p>
<p><strong>Disease severity:</strong> <em>baseline</em> factor directly affecting outcome and indirectly affecting exposure through an effect on CL</p>
<ul>
<li><p>Effect on CL through, e.g., cachexia -&gt; inflammation and proteolytic activity -&gt; high CL</p></li>
<li><p>If we’re not careful, baseline disease severity can confound the causal relationship between exposure and survival</p></li>
</ul>
</div>
<div id="why-is-this-a-problem" class="slide section level1">
<h1>Why is this a problem?</h1>
<ul>
<li>We want to know the <strong>causal</strong> effect of exposure on the outcome.
<ul>
<li>That is, if we change exposure how does the response change?</li>
</ul></li>
<li><p>The data going into these analyses are essentially observational.</p></li>
<li><p>The common cause of exposure and outcome provides a <red>backdoor path</red> for information to flow.</p></li>
</ul>
<p><img src="Confounded-Exposure-Respose_files/figure-slidy/unnamed-chunk-13-1.png" width="864" style="display: block; margin: auto auto auto 0;" /></p>
</div>
<div id="why-is-this-a-large-molecule-issue" class="slide section level1">
<h1>Why is this a large molecule issue?</h1>
<ul>
<li>For small molecules, baseline disease severity has much less of an impact on exposure</li>
</ul>
<p><img src="Confounded-Exposure-Respose_files/figure-slidy/unnamed-chunk-14-1.png" width="864" style="display: block; margin: auto auto auto 0;" /></p>
<p><strong>Weight:</strong> <em>baseline</em> factor indirectly affecting exposure (through CL)</p>
<p><strong>Disease severity:</strong> <em>baseline</em> factor directly affecting outcome</p>
</div>
<div id="why-is-this-a-one-regimen-issue" class="slide section level1">
<h1>Why is this a ‘one regimen’ issue?</h1>
<p><img src="Confounded-Exposure-Respose_files/figure-slidy/unnamed-chunk-15-1.png" width="864" style="display: block; margin: auto auto auto 0;" /></p>
<p>Weight: baseline factor indirectly affecting exposure (through CL)<br />
Disease severity: baseline factor directly affecting outcome and indirectly affecting exposure</p>
<ul>
<li>All of the variability in exposure is due to variability in CL
<ul>
<li>As a result, we can’t block the backdoor path by controlling for CL</li>
</ul></li>
<li>Adding additional dose levels to the design is one solution</li>
</ul>
</div>
<div id="solutions-when-confounding-is-due-to-baseline-factors" class="slide section level1">
<h1>Solutions when confounding is due to baseline factors</h1>
<ul>
<li>Thinking about your estimand and potential confounding ahead of time
<ul>
<li>Use DAGs to identify back door paths and how to block them without introducing other sources of bias</li>
</ul></li>
<li>Study design
<ul>
<li>Include multiple dose levels / regimens to de-couple CL and dose</li>
<li>Depending on the context, this may not be practical</li>
</ul></li>
<li>Adjusted analysis
<ul>
<li>Regression models
<ul>
<li>Include effects of common causes in the model (even if they are not statistically significant!)</li>
<li>Be careful not to include common outcomes as a predictor</li>
</ul></li>
<li>Matched analysis
<ul>
<li>Various methods for matching: propensity scores (PS), Mahalanobis distance</li>
<li>Can use machine learning or other non-parametric methods for building PS model</li>
</ul></li>
</ul></li>
</ul>
<!-- # Causal model with PD marker -->
<!-- ```{r,engine='tikz',echo=FALSE} -->
<!-- \begin{tikzpicture} -->
<!-- \tikzset{every node}=[font=\sffamily] -->
<!-- \node (v0) at (0,0) {exposure}; -->
<!-- \node (v1) at (6,0)  {Alive at 1 year}; -->
<!-- \node[align=center] (v2) at (0,-2)  {baseline\\disease severity} ; -->
<!-- \node (v3) at (-2,0) {CL}; -->
<!-- \node (v4) at (-2,2)  {Weight}; -->
<!-- \node (v5) at (0,2) {dose}; -->
<!-- \node (v6) at (3,0) {PD marker}; -->
<!-- \draw [->] (v0) edge (v6); -->
<!-- \draw [->] (v2) edge (v1); -->
<!-- \draw [->] (v4) edge (v3); -->
<!-- \draw [->] (v2) edge (v3); -->
<!-- \draw [->] (v3) edge (v0); -->
<!-- \draw [->] (v5) edge (v0); -->
<!-- \draw [->] (v6) edge (v1); -->
<!-- \end{tikzpicture} -->
<!-- ``` -->
<!-- * Weight: baseline factor indirectly affecting exposure (through CL)   -->
<!-- * Disease severity: baseline factor directly affecting outcome and indirectly affecting exposure  -->
<!-- * Does the extra information help? -->
</div>
<div id="causal-model-with-time-dependent-confounding" class="slide section level1">
<h1>Causal model with time-dependent confounding</h1>
<p><img src="Confounded-Exposure-Respose_files/figure-slidy/unnamed-chunk-16-1.png" width="864" style="display: block; margin: auto auto auto 0;" /></p>
<ul>
<li>Much more complex and DAGs don’t provide a simple solution</li>
<li>Need more sophisticated statistical tools
<ul>
<li>Marginal structural models + G-computation</li>
<li>Joint PK-TS or PK-TS-OS models</li>
</ul></li>
<li>Use early exposure measure (Dai et al., 2020)</li>
<li>Incorporate mediating biomarker (e.g., tumor size) (Kawakatsu et al., 2020)</li>
</ul>
</div>
<div id="additional-reading" class="slide section level1">
<h1>Additional reading</h1>
<ul>
<li><p>Dai HI, Vugmeyster Y, Mangal N. Characterizing Exposure-Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects. Clin Pharmacol Ther. 2020 Dec;108(6):1156–70.</p></li>
<li><p>Kawakatsu S, Bruno R, Kågedal M, Li C, Girish S, Joshi A, Wu B. Confounding factors in exposure-response analyses and mitigation strategies for monoclonal antibodies in oncology. Br J Clin Pharmacol [Internet]. 2020 Nov 20; Available from: <a href="http://dx.doi.org/10.1111/bcp.14662" class="uri">http://dx.doi.org/10.1111/bcp.14662</a></p></li>
<li><p>Hernán MA, Hernández-Díaz S, Werler MM, Mitchell AA. Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am J Epidemiol. 2002 Jan 15;155(2):176–84.</p></li>
</ul>
</div>

  <!-- dynamically load mathjax for compatibility with self-contained -->
  <script>
    (function () {
      var script = document.createElement("script");
      script.type = "text/javascript";
      script.src  = "Confounded-Exposure-Respose_files/mathjax-local/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
      document.getElementsByTagName("head")[0].appendChild(script);
    })();
  </script>

</body>
</html>
